Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+52Malignant Laryngeal Neoplasm+24Cutaneous Melanoma+20Malignant Bladder Neoplasm+20Malignant Esophageal Neoplasm+16Malignant Testicular Neoplasm+16Malignant Pancreatic Neoplasm+12Malignant Prostate Neoplasm+12Malignant Salivary Gland Neop…+12Malignant Kidney Neoplasm+8Malignant Mesothelioma+8Malignant Hypopharyngeal Neop…0Malignant Lung Neoplasm0Hodgkin Lymphoma-4Leukemia-4
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+52100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23669
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
92
activityPercentile
40

ranking row 2593746

2=Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2921
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2593747

3=Cutaneous Melanoma+2092Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4725
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
44
activityPercentile
24

ranking row 2593748

3=Malignant Bladder Neoplasm+2092Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8503
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
68
activityPercentile
48

ranking row 2593749

5=Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9789
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2593750

5=Malignant Testicular Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
393
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
20
activityPercentile
4

ranking row 2593751

7=Malignant Pancreatic Neoplasm+1276Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14876
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
88
activityPercentile
76

ranking row 2593752

7=Malignant Prostate Neoplasm+1276Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
30446
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2593754

7=Malignant Salivary Gland Neoplasm+1276Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
455
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
24
activityPercentile
12

ranking row 2593753

10=Malignant Kidney Neoplasm+864Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7587
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
64
activityPercentile
56

ranking row 2593756

10=Malignant Mesothelioma+864Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2004
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2593755

12=Malignant Hypopharyngeal Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
253
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
8
activityPercentile
8

ranking row 2593758

12=Malignant Lung Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
90121
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2593757

14=Hodgkin Lymphoma-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
751
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
32
activityPercentile
36

ranking row 2593760

14=Leukemia-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12058
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
84
activityPercentile
88

ranking row 2593759

14=Malignant Gastric Neoplasm-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7133
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
60
activityPercentile
64

ranking row 2593761

14=Malignant Penile Neoplasm-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
209
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
4

ranking row 2593763

14=Malignant Rectal Neoplasm-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4802
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
48
activityPercentile
52

ranking row 2593764

14=Malignant Thyroid Gland Neoplasm-448Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
558
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
28
activityPercentile
32

ranking row 2593762

20=Malignant Liver Neoplasm-824Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9011
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
72
activityPercentile
80

ranking row 2593765

21=Non-Hodgkin Lymphoma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11538
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
80
activityPercentile
92

ranking row 2593766

22=Malignant Anal Neoplasm-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
213
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
4
activityPercentile
20

ranking row 2593769

22=Malignant Central Nervous System Neoplasm-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7125
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
56
activityPercentile
72

ranking row 2593767

22=Multiple Myeloma-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5671
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
52
activityPercentile
68

ranking row 2593768

25=Malignant Nasopharyngeal Neoplasm-284Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
388
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
16
activityPercentile
44

ranking row 2593770

26=Malignant Breast Neoplasm-840Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
369
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
12
activityPercentile
96

ranking row 2593771

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 189171deff244f18802d02a8